After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Edwards Lifesciences Corporation (EW) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $89.18. The Edwards Lifesciences Corporation has recorded 29,604 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that EDWARDS’ AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA.
<25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Stocks Info
Edwards Lifesciences Corporation is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $89.18 and fluctuated between $89.25 as its day high and $88.39 as its day low. The current market capitalization of Edwards Lifesciences Corporation is $53.82B. A total of 1.57 million shares were traded on the day, compared to an average of 3.14M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, EW has seen 12 BUY and 14 SELL insider trades, representing the acquisition of 123,762 and the disposition of 99,921 shares. Over the last 12 months, there were 57 BUYs and 93 SELLs from insiders. Insiders purchased 729,820 shares during that period but sold 657,366.
In the most recent transaction, Ullem Scott B. sold 80,700 shares of EW for 88.54 per share on May 10. After the transaction, the CVP, Chief Financial Officer now owns 18,294 company shares. In a previous transaction on May 10, MUSSALLEM MICHAEL A sold 19,875 shares at 88.49 per share. EW shares that Chairman & CEO owns now total 81,725.
Among the insiders who sold shares, BOBO DONALD E JR disposed of 2,500 shares on May 10 at a per-share price of $89.22. This resulted in the CVP,Strategy/Corp Development holding 33,078 shares of EW after the transaction. In another insider transaction, Szyman Catherine M. sold 75,600 shares at $88.94 per share on May 09. Company shares held by the CVP, Critical Care now total 28,531.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $93.95 with high estimates of $105.00 and low estimates of $73.00. In terms of 52-week highs and lows, EW has a high of $107.92 and a low of $67.13.
As of this writing, EW has an earnings estimate of $0.65 per share for the current quarter. EPS was calculated based on a consensus of 22 estimates, with a high estimate of $0.66 per share and a lower estimate of $0.62. The company reported an EPS of $0.64 in the last quarter, which was 4.90% higher than expectations of $0.61.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $9.84, while its Total Shareholder’s Equity was $5.84B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 4.00.
